| scholarly article | Q13442814 |
| P50 | author | Heike E Daldrup-Link | Q42145500 |
| Aubie Shaw | Q47982810 | ||
| Morteza Mahmoudi | Q37830224 | ||
| Gregor Hutter | Q39186580 | ||
| P2093 | author name string | Michael Moseley | |
| Hossein Nejadnik | |||
| Stuart Goodman | |||
| Saeid Zanganeh | |||
| Ryan Spitler | |||
| Olga Lenkov | |||
| Jukka Sakari Pajarinen | |||
| Lisa Marie Coussens | |||
| P2860 | cites work | EGFRvIII antibody-conjugated iron oxide nanoparticles for magnetic resonance imaging-guided convection-enhanced delivery and targeted therapy of glioblastoma | Q39677767 |
| In vivo tumor growth is inhibited by cytosolic iron deprivation caused by the expression of mitochondrial ferritin | Q40270843 | ||
| Ferric iron increases ROS formation, modulates cell growth and enhances genotoxic damage by 4-hydroxynonenal in human colon tumor cells | Q42166135 | ||
| MR imaging of tumor-associated macrophages | Q42214227 | ||
| An unrestrained proinflammatory M1 macrophage population induced by iron impairs wound healing in humans and mice | Q42652064 | ||
| Lysosomal degradation of the carboxydextran shell of coated superparamagnetic iron oxide nanoparticles and the fate of professional phagocytes | Q42925931 | ||
| FDA report: Ferumoxytol for intravenous iron therapy in adult patients with chronic kidney disease | Q43143474 | ||
| Human cytomegalovirus-induced host cell enlargement is iron dependent | Q44919373 | ||
| Structural characterization of iron oxide/hydroxide nanoparticles in nine different parenteral drugs for the treatment of iron deficiency anaemia by electron diffraction (ED) and X-ray powder diffraction (XRPD). | Q44979650 | ||
| Surface-modified superparamagnetic nanoparticles for drug delivery: preparation, characterization, and cytotoxicity studies | Q45070455 | ||
| Dynamical interactions between multiple cancers. | Q46036652 | ||
| Role of alveolar macrophage chemotaxis and phagocytosis in pulmonary clearance responses to inhaled particles: comparisons among rodent species | Q46216647 | ||
| SPION primes THP1 derived M2 macrophages towards M1-like macrophages | Q46784383 | ||
| The potential of ferumoxytol nanoparticle magnetic resonance imaging, perfusion, and angiography in central nervous system malignancy: a pilot study | Q48213433 | ||
| Ionising radiation-free whole-body MRI versus (18)F-fluorodeoxyglucose PET/CT scans for children and young adults with cancer: a prospective, non-randomised, single-centre study. | Q50719431 | ||
| Antibody therapy targeting the CD47 protein is effective in a model of aggressive metastatic leiomyosarcoma | Q24631455 | ||
| Ferumoxytol for the treatment of iron deficiency | Q30454001 | ||
| Non-invasive mapping of deep-tissue lymph nodes in live animals using a multimodal PET/MRI nanoparticle. | Q33841759 | ||
| Iron intake, oxidative stress-related genes (MnSOD and MPO) and prostate cancer risk in CARET cohort | Q33986231 | ||
| Magnetic antibody-linked nanomatchmakers for therapeutic cell targeting | Q34246195 | ||
| The cellular and molecular origin of tumor-associated macrophages | Q34378833 | ||
| Imaging macrophages with nanoparticles | Q34399530 | ||
| A targeted approach to cancer imaging and therapy | Q34523300 | ||
| MRI of tumor-associated macrophages with clinically applicable iron oxide nanoparticles | Q35196287 | ||
| Oh the irony: Iron as a cancer cause or cure? | Q35343242 | ||
| TH2-Polarized CD4(+) T Cells and Macrophages Limit Efficacy of Radiotherapy | Q35572179 | ||
| Cell-delivered magnetic nanoparticles caused hyperthermia-mediated increased survival in a murine pancreatic cancer model. | Q35694284 | ||
| Alcohol, iron-associated oxidative stress, and cancer | Q36213172 | ||
| Tumour-associated macrophages act as a slow-release reservoir of nano-therapeutic Pt(IV) pro-drug. | Q36459188 | ||
| Recent advances in iron oxide nanocrystal technology for medical imaging | Q36658332 | ||
| A drug repositioning approach identifies tricyclic antidepressants as inhibitors of small cell lung cancer and other neuroendocrine tumors. | Q37395737 | ||
| Tumor-associated macrophages (TAM) as major players of the cancer-related inflammation | Q37594369 | ||
| Development of novel tumor-targeted theranostic nanoparticles activated by membrane-type matrix metalloproteinases for combined cancer magnetic resonance imaging and therapy | Q37624281 | ||
| State of the iron: how to diagnose and efficiently treat iron deficiency anemia in inflammatory bowel disease | Q38037260 | ||
| The prognostic impact of tumor-associated macrophages and intra-tumoral apoptosis in non-small cell lung cancer. | Q38128517 | ||
| Superparamagnetic iron oxide nanoparticles in biomedicine: applications and developments in diagnostics and therapy | Q38134638 | ||
| Macrophages associated with tumors as potential targets and therapeutic intermediates | Q38211726 | ||
| In vivo mononuclear cell tracking using superparamagnetic particles of iron oxide: feasibility and safety in humans. | Q38468041 | ||
| Expression of Sox2 in breast cancer cells promotes the recruitment of M2 macrophages to tumor microenvironment | Q38936048 | ||
| Somatic differentiation and MR imaging of magnetically labeled human embryonic stem cells | Q39302728 | ||
| Iron oxide nanoparticle-induced epidermal growth factor receptor expression in human stem cells for tumor therapy. | Q39448023 | ||
| Effect of ferric ions on reactive oxygen species formation, cervical cancer cell lines growth and E6/E7 oncogene expression. | Q39636624 | ||
| P433 | issue | 11 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | nanoparticle | Q61231 |
| inflammation | Q101991 | ||
| macrophage | Q184204 | ||
| P304 | page(s) | 986-994 | |
| P577 | publication date | 2016-09-26 | |
| P1433 | published in | Nature Nanotechnology | Q920399 |
| P1476 | title | Iron oxide nanoparticles inhibit tumour growth by inducing pro-inflammatory macrophage polarization in tumour tissues | |
| P478 | volume | 11 |
| Q37716856 | "Pumping iron"-how macrophages handle iron at the systemic, microenvironmental, and cellular levels |
| Q45966683 | A Novel Theranostic Strategy for MMP-14-Expressing Glioblastomas Impacts Survival. |
| Q46372070 | Activatable Singlet Oxygen Generation from Lipid Hydroperoxide Nanoparticles for Cancer Therapy. |
| Q91770878 | Acute Iron Deprivation Reprograms Human Macrophage Metabolism and Reduces Inflammation In Vivo |
| Q93200227 | Altered Iron Metabolism and Impact in Cancer Biology, Metastasis, and Immunology |
| Q60930257 | Anti-tumor macrophages activated by ferumoxytol combined or surface-functionalized with the TLR3 agonist poly (I : C) promote melanoma regression |
| Q91615458 | Application of Gray Level co-Occurrence Matrix Algorithm for Detection of Discrete Structural Changes in Cell Nuclei After Exposure to Iron Oxide Nanoparticles and 6-Hydroxydopamine |
| Q64890029 | Aromatic secondary amine-functionalized fluorescent NO probes: improved detection sensitivity for NO and potential applications in cancer immunotherapy studies. |
| Q60919588 | Bioactive Nanoparticles for Cancer Immunotherapy |
| Q57821638 | Biodistribution and Tumors MRI Contrast Enhancement of Magnetic Nanocubes, Nanoclusters, and Nanorods in Multiple Mice Models |
| Q99579060 | Biointerface engineering nanoplatforms for cancer-targeted drug delivery |
| Q60923217 | Biological Effects of Nanoparticles on Macrophage Polarization in the Tumor Microenvironment |
| Q39271088 | Biomaterial strategies for generating therapeutic immune responses |
| Q90928865 | Biomaterial-assisted targeted modulation of immune cells in cancer treatment |
| Q55534075 | CCL5-deficiency enhances intratumoral infiltration of CD8+ T cells in colorectal cancer. |
| Q92702538 | Cancer Nano-Immunotherapy from the Injection to the Target: The Role of Protein Corona |
| Q38646361 | Cancer Nanomedicine: Lessons for Immuno-Oncology |
| Q96577200 | Cancer nanomedicine meets immunotherapy: opportunities and challenges |
| Q90152560 | Catalytic antimicrobial robots for biofilm eradication |
| Q55360082 | Cell iron status influences macrophage polarization. |
| Q96136659 | Cellular backpacks for macrophage immunotherapy |
| Q39147958 | Colloidal capsules: nano- and microcapsules with colloidal particle shells. |
| Q91555004 | Combined chemo-magnetic field-photothermal breast cancer therapy based on porous magnetite nanospheres |
| Q92257920 | Current Strategies to Target Tumor-Associated-Macrophages to Improve Anti-Tumor Immune Responses |
| Q39330984 | Delivering safer immunotherapies for cancer |
| Q38798699 | Designed synthesis and surface engineering strategies of magnetic iron oxide nanoparticles for biomedical applications. |
| Q59812887 | Designing multifunctional cancer-targeted nanosystem for magnetic resonance molecular imaging-guided theranostics of lung cancer |
| Q92267162 | Development of Adamantane-Conjugated TLR7/8 Agonists for Supramolecular Delivery and Cancer Immunotherapy |
| Q64070961 | Drug-free mannosylated liposomes inhibit tumor growth by promoting the polarization of tumor-associated macrophages |
| Q47685899 | Effects of engineered nanoparticles on the innate immune system |
| Q57293807 | Elimination of CD4HLA-G T cells overcomes castration-resistance in prostate cancer therapy |
| Q98771484 | Emerging Adjuvants for Cancer Immunotherapy |
| Q47860087 | Emerging Biomedical Applications of Enzyme-Like Catalytic Nanomaterials |
| Q47720042 | Emerging Strategies of Cancer Therapy Based on Ferroptosis. |
| Q60923345 | Engineering Nanoparticles for Targeted Remodeling of the Tumor Microenvironment to Improve Cancer Immunotherapy |
| Q89475558 | Enhancing cancer immunotherapy with nanomedicine |
| Q47263594 | Evolution and Clinical Translation of Drug Delivery Nanomaterials |
| Q64093293 | Exosomes from M1-Polarized Macrophages Enhance Paclitaxel Antitumor Activity by Activating Macrophages-Mediated Inflammation |
| Q92615413 | FDA-approved ferumoxytol displays anti-leukaemia efficacy against cells with low ferroportin levels |
| Q92128570 | Fabrication of Maghemite Nanoparticles with High Surface Area |
| Q90298857 | Feraheme (Ferumoxytol) Is Recognized by Proinflammatory and Anti-inflammatory Macrophages via Scavenger Receptor Type AI/II |
| Q64989624 | Ferritin: A potential serum marker for lymph node metastasis in head and neck squamous cell carcinoma. |
| Q92031701 | Ferumoxytol Attenuates the Function of MDSCs to Ameliorate LPS-Induced Immunosuppression in Sepsis |
| Q46071655 | Ferumoxytol vs. Gadolinium agents for contrast-enhanced MRI: Thoughts on evolving indications, risks, and benefits. |
| Q48180700 | Fluorine-19 Magnetic Resonance Imaging and Positron Emission Tomography of Tumor-Associated Macrophages and Tumor Metabolism. |
| Q55280335 | IPSC‑MSC inhibition assessment in Raw 264.7 cells following oxygen and glucose deprivation reveals a distinct function for cardiopulmonary resuscitation. |
| Q61443104 | Imaging endogenous macrophage iron deposits reveals a metabolic biomarker of polarized tumor macrophage infiltration and response to CSF1R breast cancer immunotherapy |
| Q50153603 | Immunological Effects of Iron Oxide Nanoparticles and Iron-based Complex Drug Formulations: Therapeutic Benefits, Toxicity, Mechanistic Insights, and Translational Considerations |
| Q39224331 | Immunomodulatory Nanomedicine |
| Q90053061 | Immunomodulatory Nanosystems |
| Q64291040 | Impact of Locally Administered Carboxydextran-Coated Super-Paramagnetic Iron Nanoparticles on Cellular Immune Function |
| Q55711287 | Improved sensitivity of cellular MRI using phase-cycled balanced SSFP of ferumoxytol nanocomplex-labeled macrophages at ultrahigh field. |
| Q92644551 | Improving nanotherapy delivery and action through image-guided systems pharmacology |
| Q92380653 | Improving the efficacy of osteosarcoma therapy: combining drugs that turn cancer cell 'don't eat me' signals off and 'eat me' signals on |
| Q55039815 | In Vivo MR Imaging of Tumor-Associated Macrophages: The Next Frontier in Cancer Imaging. |
| Q55015760 | Interferon-Gamma at the Crossroads of Tumor Immune Surveillance or Evasion. |
| Q64230500 | Iron Homeostasis in the Lungs-A Balance between Health and Disease |
| Q47161414 | Iron Induces Anti-tumor Activity in Tumor-Associated Macrophages. |
| Q64075548 | Iron Metabolism in Liver Cancer Stem Cells |
| Q41240058 | Iron Oxide Nanozyme: A Multifunctional Enzyme Mimetic for Biomedical Applications. |
| Q92431953 | Iron accumulation in tumor-associated macrophages marks an improved overall survival in patients with lung adenocarcinoma |
| Q58790023 | Iron and magnetic: new research direction of the ferroptosis-based cancer therapy |
| Q61796322 | Iron as a Central Player and Promising Target in Cancer Progression |
| Q89494363 | Iron overloaded polarizes macrophage to proinflammation phenotype through ROS/acetyl-p53 pathway |
| Q60045751 | Iron oxide nanoparticles as nanocarriers to improve chlorin e6-based sonosensitivity in sonodynamic therapy |
| Q55007574 | Iron(III)-Tannic Molecular Nanoparticles Enhance Autophagy effect and T1 MRI Contrast in Liver Cell Lines. |
| Q54936964 | Iron-dependent cell death as executioner of cancer stem cells. |
| Q41634111 | Low toxic maghemite nanoparticles for theranostic applications. |
| Q92134682 | Magnetogel Nanospheres Composed of Cisplatin-Loaded Alginate/B-Cyclodextrin as Controlled Release Drug Delivery |
| Q47444271 | Mapping the microscale origins of magnetic resonance image contrast with subcellular diamond magnetometry. |
| Q46071048 | Mechanisms and Barriers in Cancer Nanomedicine: Addressing Challenges, Looking for Solutions |
| Q99583885 | Metabolic reprograming of tumor-associated macrophages |
| Q38738754 | Molecular Imaging in Nanotechnology and Theranostics |
| Q89638581 | Monitoring innate immune cell dynamics in the glioma microenvironment by magnetic resonance imaging and multiphoton microscopy (MR-MPM) |
| Q57793576 | Multi-hierarchical profiling the structure-activity relationships of engineered nanomaterials at nano-bio interfaces |
| Q49391681 | Multifunctional nanoparticles for cancer immunotherapy: A groundbreaking approach for reprogramming malfunctioned tumor environment |
| Q47095093 | Multimodal Theranostic Nanoformulations Permit Magnetic Resonance Bioimaging of Antiretroviral Drug Particle Tissue-Cell Biodistribution |
| Q46454164 | Multiscale technologies for treatment of ischemic cardiomyopathy |
| Q50048512 | Nanocage-Therapeutics Prevailing Phagocytosis and Immunogenic Cell Death Awakens Immunity against Cancer |
| Q89909976 | Nanomaterials for modulating innate immune cells in cancer immunotherapy |
| Q39294509 | Nanomaterials in the Context of Type 2 Immune Responses-Fears and Potentials. |
| Q39283111 | Nanomedicine Strategies to Target Tumor-Associated Macrophages |
| Q44659009 | Nanomedicine: An iron age for cancer therapy |
| Q92592099 | Nanoparticle Interactions with the Tumor Microenvironment |
| Q61816620 | Nanoparticle enhanced MRI can monitor macrophage response to CD47 mAb immunotherapy in osteosarcoma |
| Q97526550 | Nanoparticle-Mediated Drug Delivery for Treatment of Ischemic Heart Disease |
| Q55633505 | Nanoparticle-Mediated Therapeutic Agent Delivery for Treating Metastatic Breast Cancer-Challenges and Opportunities. |
| Q33772186 | Nanoparticle-based drug delivery systems: What can they really do in vivo? |
| Q95642943 | Nanotechnology Promotes Genetic and Functional Modifications of Therapeutic T Cells Against Cancer |
| Q90649853 | Nanotherapeutics to Modulate the Compromised Micro-Environment for Lung Cancers and Chronic Obstructive Pulmonary Disease |
| Q90340146 | Near-infrared light and tumor microenvironment dual responsive size-switchable nanocapsules for multimodal tumor theranostics |
| Q38689637 | Next-generation superparamagnetic iron oxide nanoparticles for cancer theranostics |
| Q47218919 | Novel Weed-Extracted Silver Nanoparticles and Their Antibacterial Appraisal against a Rare Bacterium from River and Sewage Treatment Plan. |
| Q51742009 | PEG/Dextran Double Layer Influences Fe Ion Release and Colloidal Stability of Iron Oxide Nanoparticles. |
| Q64887288 | Paclitaxel Magnetic Core⁻Shell Nanoparticles Based on Poly(lactic acid) Semitelechelic Novel Block Copolymers for Combined Hyperthermia and Chemotherapy Treatment of Cancer. |
| Q38688207 | Paclitaxel nanoparticle awakens immune system to fight against cancer |
| Q93129284 | Pre-clinical study of iron oxide nanoparticles fortified artesunate for efficient targeting of malarial parasite |
| Q89736571 | Prediction of Anti-cancer Nanotherapy Efficacy by Imaging |
| Q89626384 | Profiles of immune cell infiltration and immune-related genes in the tumor microenvironment of osteosarcoma |
| Q39267549 | Progress in tumor-associated macrophage (TAM)-targeted therapeutics |
| Q58698857 | Protein nanoparticles with ligand-binding and enzymatic activities |
| Q64904799 | Quantification of Nanoparticle Enhancement in Polarized Breast Tumor Macrophage Deposits by Spatial Analysis of MRI and Histological Iron Contrast Using Computer Vision. |
| Q89697316 | Recent Advancements of Magnetic Nanomaterials in Cancer Therapy |
| Q91778990 | Redox Regulation via Glutaredoxin-1 and Protein S-Glutathionylation |
| Q47588064 | SPARCL1 suppresses osteosarcoma metastasis and recruits macrophages by activation of canonical WNT/β-catenin signaling through stabilization of the WNT-receptor complex |
| Q89985480 | Silver nanoparticles selectively treat triple-negative breast cancer cells without affecting non-malignant breast epithelial cells in vitro and in vivo |
| Q97425794 | Substrate stiffness modulates bone marrow-derived macrophage polarization through NF-κB signaling pathway |
| Q92288323 | Surface Modification of Polymeric Nanoparticles with M2pep Peptide for Drug Delivery to Tumor-Associated Macrophages |
| Q64266934 | Surface radio-mineralisation mediates chelate-free radiolabelling of iron oxide nanoparticles |
| Q92926068 | Surface-enhanced Resonance Raman Scattering Nanoprobe Ratiometry for Detecting Microscopic Ovarian Cancer via Folate Receptor Targeting |
| Q94479939 | Sustainable synthesis of nanoscale zerovalent iron particles for environmental remediation |
| Q40280801 | Synthetic nanovaccines for immunotherapy. |
| Q92735076 | Syringeable immunotherapeutic nanogel reshapes tumor microenvironment and prevents tumor metastasis and recurrence |
| Q47195452 | Systemic administration of β-glucan of 200 kDa modulates melanoma microenvironment and suppresses metastatic cancer. |
| Q89737194 | TFRC promotes epithelial ovarian cancer cell proliferation and metastasis via up-regulation of AXIN2 expression |
| Q38677432 | Tailoring Biomaterials for Cancer Immunotherapy: Emerging Trends and Future Outlook. |
| Q98290954 | Tandem-Mass-Tag Based Proteomic Analysis Facilitates Analyzing Critical Factors of Porous Silicon Nanoparticles in Determining Their Biological Responses under Diseased Condition |
| Q57291853 | Targeted Theranostic Nanoparticles for Brain Tumor Treatment |
| Q61051844 | Targeting Macrophages as a Potential Therapeutic Intervention: Impact on Inflammatory Diseases and Cancer |
| Q99582952 | Targeting ferroptosis for cancer therapy: exploring novel strategies from its mechanisms and role in cancers |
| Q33757232 | Targeting iron metabolism in drug discovery and delivery |
| Q90479600 | Targeting of Hepatic Macrophages by Therapeutic Nanoparticles |
| Q104064726 | Tellurium doped zinc imidazole framework (Te@ZIF-8) for quantitative determination of hydrogen peroxide from serum of pancreatic cancer patients |
| Q48146534 | Ten Things You Might Not Know about Iron Oxide Nanoparticles |
| Q37690819 | The Current State of Nanoparticle-Induced Macrophage Polarization and Reprogramming Research |
| Q97526987 | The Role of Tumor-Associated Myeloid Cells in Modulating Cancer Therapy |
| Q49634844 | The role of macrophage phenotype in regulating the response to radiation therapy |
| Q93042159 | Theranostics Applications of Nanoparticles in Cancer Immunotherapy |
| Q88502315 | Theranostics and metabolotheranostics for precision medicine in oncology |
| Q90733109 | Therapeutic Targeting of Neutrophil Granulocytes in Inflammatory Liver Disease |
| Q92987543 | Therapeutic targeting of trained immunity |
| Q61135131 | Topical ferumoxytol nanoparticles disrupt biofilms and prevent tooth decay in vivo via intrinsic catalytic activity |
| Q64947982 | Transferrin receptor 1 in cancer: a new sight for cancer therapy. |
| Q92092897 | Transformable hybrid semiconducting polymer nanozyme for second near-infrared photothermal ferrotherapy |
| Q99711957 | Transient coating of γ-Fe2O3 nanoparticles with glutamate for its delivery to and removal from brain nerve terminals |
| Q47962563 | Tumor-associated macrophages, nanomedicine and imaging: the axis of success in the future of cancer immunotherapy |
| Q41318642 | Tumor-associated macrophages, potential targets for cancer treatment. |
| Q37671174 | Tumor-associated macrophages: from basic research to clinical application |
| Q48638999 | Tumor-associated myeloid cells: new understandings on their metabolic regulation and their influence in cancer immunotherapy |
| Q95276643 | Understanding Metal Dynamics Between Cancer Cells and Macrophages: Competition or Synergism? |
| Q90356749 | Vanadium Dioxide Nanocoating Induces Tumor Cell Death through Mitochondrial Electron Transport Chain Interruption |
| Q92615407 | Winning the war with iron |
| Q94589419 | [Anti-CD206 antibody-conjugated Fe3O4-based PLGA nanoparticles selectively promotes M1 polarization of tumorassociated macrophages in mice] |
| Q90067372 | [Effects of magnetic thermotherapy mediated by magnetic nanocomposite PEG-APTESMNP on proliferation of liver cancer cells] |
| Q94589631 | [T1-weighted magnetic resonance imaging contrast agents and their theranostic nanoprobes] |
Search more.